Having graduated in medicine from Kings College in London, Guy practiced in Opthalmology and neurosurgery before moving to a career in business.
His experience includes drug development at Eli Lilly and working in Healthcare investment banking first as a stock analyst with Barclays de Zoete Wedd and then in mergers and acquisitions with JPMorgan
Part of the demerger of ICI and IPO of Zeneca (now AstraZeneca) and the Wellcome £2.3bn stock offering
CEO of Cancer Research Ventures, the technology transfer company for the Cancer Research Campaign
Chairman of Cambridge Cognition Ltd and CEO of Deontics Ltd
